Autopsy report · NCT03032536
Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers
Cause of deathFunding or business
“Sponsor decision.”
Life of this trial
- Ran for about 5 months before it stopped.
- 54 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Alios Biopharma Inc.
- Sponsor type
- Industry
- Conditions
- Hepatitis B; Chronic Hepatitis B; Viral Hepatitis B
- Interventions
- AL-3778; Entecavir; Tenofovir disoproxil fumarate
- Participants
- 54
- Sites
- 2
- Countries
- New Zealand
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.